Most adults with cancer are over 65 years of age, and this cohort is expected to grow
exponentially. Older adults have an increased burden of comorbidities and risk of …

What is known and objectives Most antineoplastic drugs are highly toxic and have low
therapeutic indexes, which can result in drug‐related problems. In this context, pharmacist …

Background Clinical pharmacists have important roles in implementing scientifically valid
knowledge and advice on safe, reasonable use of pharmaceuticals. Clinical pharmacy …

Background Studies have identified non-adherence as one of the major contributing factors
to treatment failure in chronic myelogenous leukemia (CML) patients receiving imatinib …

Although oncology pharmacists have been involved in the care of cancer patients for over
50 years, the role of the oncology pharmacist continues to expand. Initially, pharmacists …

Less than 1% of India's 1.2 billion population has access to palliative care. The efforts by
pioneers over the last quarter of a century have resulted in progress, some of which may …

Background Oncology pharmacists are capable of providing medication therapy
management (MTM) because of their level of training, practice experiences, and …

Interprofessional care is exhibited in outpatient oncology practices where practitioners from
a myriad of specialties (eg, oncology, nursing, pharmacy, health informatics and others) …

Background With the introduction of oral chemotherapy, the paradigm for cancer treatment is
shifting. Use of oral chemotherapy agents offers a non-invasive option for patients with …

Polypharmacy is prevalent in older adults with cancer and may be advantageous for the
management of certain chronic disease states, but uncertainty exists regarding potential …